Jim Simons Sensei Biotherapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 177,300 shares of SNSE stock, worth $54,963. This represents 0.0% of its overall portfolio holdings.
Number of Shares
177,300
Previous 156,800
13.07%
Holding current value
$54,963
Previous $78,000
11.54%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SNSE
# of Institutions
23Shares Held
1.97MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA586KShares$181,5280.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX450KShares$139,4880.02% of portfolio
-
Catalio Capital Management, LP New York, NY294KShares$91,2550.03% of portfolio
-
Geode Capital Management, LLC Boston, MA151KShares$46,7190.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY109KShares$33,6830.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $9.52M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...